Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., headquartered in the United States, is a prominent player in the biotechnology industry, specialising in the development and manufacturing of innovative medical devices and biopharmaceuticals. Founded in 1984, the company has achieved significant milestones, including advancements in its core product lines, which focus on hyaluronic acid-based solutions for various medical applications. With a strong presence in the orthopaedic, ophthalmic, and aesthetic markets, Lifecore is recognised for its commitment to quality and precision. The company’s unique offerings, such as its proprietary manufacturing processes, set it apart from competitors, ensuring high standards and efficacy. Lifecore Biomedical continues to solidify its market position through strategic partnerships and a dedication to research and development, making it a trusted name in the biomedical field.
DitchCarbon Score
How does Lifecore Biomedical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lifecore Biomedical, Inc.'s score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Lifecore Biomedical, Inc.'s reported carbon emissions
Lifecore Biomedical, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting its emissions. In the context of the biomedical industry, companies are increasingly recognising the importance of sustainability and are encouraged to adopt comprehensive strategies to measure and reduce their carbon footprint. Lifecore Biomedical's future initiatives may include setting specific reduction targets aligned with industry standards, such as the Science Based Targets initiative (SBTi), to enhance their environmental responsibility and transparency. As the industry evolves, it is crucial for Lifecore Biomedical to establish clear climate commitments to contribute positively to global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lifecore Biomedical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
